EVERSANA Opens New Office In London
EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, has opened a new office in the heart of London’s Holborn district to serve the company’s growing client and team needs. According to sources, this spacious open-concept facility will be home to a rapidly increasing European team and serve as a destination to connect […]
NASA Selects Teams To Study Earth’s Upper Atmosphere
NASA has selected three investigation teams to join the agency’s Geospace Dynamics Constellation (GDC) mission science team in studying Earth’s upper atmosphere, as well as five additional investigations that will be under consideration for inclusion in the mission. GDC is a coordinated group of satellites that will provide the first direct global measurements of the […]
Eisai Updates On Long Term Outcomes of Investigational Aβ protofibril antibody lecanemab
Eisai Co., Ltd. announced that an article about long-term health outcomes of its investigational anti-amyloid-beta (Aβ) protofibril antibody lecanemab in people living with early Alzheimer’s disease (AD) using simulation modeling was published in a peer-reviewed journal Neurology and Therapy. In this simulation, lecanemab treatment is estimated to potentially slow the rate of disease progression, maintaining treated […]
VTrips Acquires Southern Vacation Rentals
VTrips, one of the fastest-growing vacation rental management companies in the United States, announced the acquisition of Southern Vacation Rentals on April 1. With operations stretching from the Florida Panhandle to the Alabama Gulf Coast, Southern Vacation Rentals adds 1,120 vacation rental properties and 123 team members to the VTrips portfolio. VTrips Chief Growth Officer Sandra Brahn said the addition of Southern Vacation […]
RVAC Completes Its Series B financing
RVAC Medicines Pte. Ltd. (“RVAC”), an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC Group (“CBC”), recently announced the completion of its series B financing, bringing the company’s total funds raised since its inception in June 2021 to US$140 million. RVAC aims to address unmet medical needs, particularly in emerging markets, through novel vaccines and therapeutics including […]
Galliott Capital Advisors Appoints Robert Mourad as Chief Portfolio Strategist
Galliott Capital Advisors, the independent wealth advisory firm appoints Robert Mourad as the Chief Portfolio Strategist. Mr. Mourad will also serve as Executive Director of Products & Services, responsible for working directly with the firm’s clients on portfolio construction and partnering with Galliott’s advisors on growing their business. Galliott, founded in 2020 by Antoine Souma, focuses on the […]